Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 2.040
Filter
1.
Appl Microbiol Biotechnol ; 108(1): 462, 2024 Sep 12.
Article in English | MEDLINE | ID: mdl-39264460

ABSTRACT

Bioinformatic analysis revealed that the genomes of ubiquitous Penicillium spp. might carry dozens of biosynthetic gene clusters (BGCs), yet many clusters have remained uncharacterized. In this study, a detailed investigation of co-culture fermentation including the basidiomycete Armillaria mellea CPCC 400891 and the P. brasilianum CGMCC 3.4402 enabled the isolation of five new compounds including two bisabolene-type sesquiterpenes (arpenibisabolanes A and B), two carotane-type sesquiterpenes (arpenicarotanes A and B), and one polyketide (arpenichorismite A) along with seven known compounds. The assignments of their structures were deduced by the extensive analyses of detailed spectroscopic data, electronic circular dichroism spectra, together with delimitation of the biogenesis. Most new compounds were not detected in monocultures under the same fermentation conditions. Arpenibisabolane A represents the first example of a 6/5-fused bicyclic bisabolene. The bioassay of these five new compounds exhibited no cytotoxic activities in vitro against three human cancer cell lines (A549, MCF-7, and HepG2). Moreover, sequence alignments and bioinformatic analysis to other metabolic pathways, two BGCs including Pb-bis and Pb-car, responsible for generating sesquiterpenoids from co-culture were identified, respectively. Furthermore, based on the chemical structures and deduced gene functions of the two clusters, a hypothetic metabolic pathway for biosynthesizing induced sesquiterpenoids was proposed. These results demonstrated that the co-culture approach would facilitate bioprospecting for new metabolites even from the well-studied microbes. Our findings would provide opportunities for further understanding of the biosynthesis of intriguing sesquiterpenoids via metabolic engineering strategies. KEY POINTS: • Penicillium and Armillaria co-culture facilitates the production of diverse secondary metabolites • Arpenibisabolane A represents the first example of 6/5-fused bicyclic bisabolenes • A hypothetic metabolic pathway for biosynthesizing induced sesquiterpenoids was proposed.


Subject(s)
Armillaria , Coculture Techniques , Fermentation , Penicillium , Secondary Metabolism , Sesquiterpenes , Armillaria/metabolism , Armillaria/genetics , Penicillium/metabolism , Penicillium/genetics , Penicillium/chemistry , Sesquiterpenes/metabolism , Sesquiterpenes/chemistry , Humans , Multigene Family , Cell Line, Tumor , Biosynthetic Pathways/genetics , Polyketides/metabolism , Polyketides/chemistry , Polyketides/isolation & purification , Hep G2 Cells
2.
J Am Chem Soc ; 146(38): 26351-26359, 2024 Sep 25.
Article in English | MEDLINE | ID: mdl-39265189

ABSTRACT

The first total synthesis of the pentacyclic phenylnaphthacenoid type II polyketide antibiotic formicamycin H is described. A key feature of the synthesis involves the convergent, regioselective assembly of the tetracyclic core via ruthenium-catalyzed α-ketol-benzocyclobutenone [4 + 2] cycloaddition. Double dehydration of the diol-containing cycloadduct provides an achiral enone, which upon asymmetric nucleophilic epoxidation and further manipulations delivers the penultimate tetracyclic trichloride in enantiomerically enriched form. Subsequent chemo- and atroposelective Suzuki cross-coupling of the tetracyclic trichloride introduces the E-ring to complete the total synthesis. Single-crystal X-ray diffraction analyses of two model compounds suggest that the initially assigned stereochemistry of the axially chiral C6-C7 linkage may require revision.


Subject(s)
Anti-Bacterial Agents , Cycloaddition Reaction , Ruthenium , Ruthenium/chemistry , Catalysis , Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/chemistry , Stereoisomerism , Hydrogen/chemistry , Polyketides/chemistry , Polyketides/chemical synthesis , Naphthacenes/chemistry , Naphthacenes/chemical synthesis , Molecular Structure
3.
Mar Drugs ; 22(9)2024 Aug 26.
Article in English | MEDLINE | ID: mdl-39330265

ABSTRACT

Three new polyketides, including three ester derivatives (1, 3, and 5) and a new natural product, which was a benzoquinone derivative, embelin A (4), together with nine known ones (2 and 6-13), were isolated from the mangrove-derived fungus Penicillium sp. SCSIO 41411. Their structures were determined by detailed NMR and MS spectroscopic analyses. The X-ray single-crystal diffraction analysis of 4 was described for the first time. Compound 9 displayed obvious inhibition against PDE4 with an inhibitory ratio of 40.78% at 10 µM. Compound 12 showed DPPH radical scavenging activity, with an EC50 of 16.21 µg/mL, compared to the positive control (ascorbic acid, EC50, 11.22 µg/mL). Furthermore, compound 4 exhibited cytotoxicity against PC-3 and LNCaP with IC50 values of 18.69 and 31.62 µM, respectively.


Subject(s)
Penicillium , Polyketides , Penicillium/chemistry , Polyketides/pharmacology , Polyketides/chemistry , Polyketides/isolation & purification , Humans , Cell Line, Tumor , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Crystallography, X-Ray , Molecular Structure
4.
Mar Drugs ; 22(9)2024 Sep 05.
Article in English | MEDLINE | ID: mdl-39330288

ABSTRACT

Twelve compounds, including four undescribed cytochalasins, xylariachalasins A-D (1-4), four undescribed polyketides (5-8), and four known cytochalasins (9-12), were isolated from the mangrove endophytic fungus Xylaria arbuscula QYF. Their structures and absolute configurations were established by extensive spectroscopic analyses (1D and 2D NMR, HRESIMS), electronic circular dichroism (ECD) calculations, 13C NMR calculation and DP4+ analysis, single-crystal X-ray diffraction, and the modified Mosher ester method. Compounds 1 and 2 are rare cytochalasin hydroperoxides. In bioactivity assays, Compound 2 exhibited moderate antimicrobial activities against Staphylococcus aureus and Candida albicans with MIC values of 12.5 µM for both Compound 10 exhibited significant cytotoxic activity against MDA-MB-435 with an IC50 value of 3.61 ± 1.60 µM.


Subject(s)
Candida albicans , Cytochalasins , Microbial Sensitivity Tests , Polyketides , Staphylococcus aureus , Xylariales , Polyketides/pharmacology , Polyketides/chemistry , Polyketides/isolation & purification , Cytochalasins/pharmacology , Cytochalasins/chemistry , Cytochalasins/isolation & purification , Xylariales/chemistry , Staphylococcus aureus/drug effects , Candida albicans/drug effects , Cell Line, Tumor , Humans , Antineoplastic Agents/pharmacology , Antineoplastic Agents/chemistry , Antineoplastic Agents/isolation & purification , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Molecular Structure , Endophytes/chemistry , Crystallography, X-Ray
5.
J Nat Prod ; 87(9): 2335-2342, 2024 Sep 27.
Article in English | MEDLINE | ID: mdl-39279157

ABSTRACT

Moringadepsin (6) and chaetone B (7) were isolated by us in the course of a conventional chemical screening of Morinagamyces vermicularis CBS 303.81, a fungus belonging to the relatively underexplored family Schizotheciaceae of the phylum Ascomycota. Since these metabolites did not account for the antifungal activity observed in a crude extract of this fungus, we utilized an MS/MS-based molecular networking approach to get a thorough insight into the secondary metabolites produced by this strain. Manual annotation of high-resolution fragmentation mass spectra by CANOPUS classified a major molecular family as putatively new thiodiketopiperazines. However, these results were opposite to the results of ChemWalker analysis based solely on MS/MS data, assigning these metabolites as various polyketides. Thus, targeted preparative HPLC isolation focusing on the most abundant features within this major molecular family resulted in the isolation of five secondary metabolites. Their structures were elucidated based on HRMS and NMR data as four new thiodiketopiperazine derivatives, botryosulfuranols D-G (1-4), alongside the known botryosulfuranol A (5). Compounds 1-3 and 5 exhibited moderate to weak antifungal activity against different test strains, accounting for the initial antifungal activity observed for its crude extract. Our study stressed the importance of full NMR-based structure elucidation for metabolomics research.


Subject(s)
Ascomycota , Antifungal Agents/pharmacology , Antifungal Agents/chemistry , Antifungal Agents/isolation & purification , Ascomycota/chemistry , Chromatography, High Pressure Liquid/methods , Microbial Sensitivity Tests , Molecular Structure , Polyketides/pharmacology , Polyketides/chemistry , Polyketides/isolation & purification , Tandem Mass Spectrometry/methods
6.
Org Lett ; 26(36): 7632-7637, 2024 Sep 13.
Article in English | MEDLINE | ID: mdl-39235108

ABSTRACT

Penicillium daleae L3SO is a fungus isolated from the rhizospheric soil of the chloroplast-deficient plant Monotropa uniflora. A chemical study on the rice fermentation of this fungus led to the isolation and identification of two cage-like polyketides, penidaleodiolide A (1) and its biosynthetic-related congener penidaleodiolide B (2). The structures of 1 and 2 were determined by a combination of extensive spectroscopic analysis, biosynthetic consideration, chemical derivatization, and computational methods. Compound 1 harbors an unusual tricyclo[4.3.04,9]nonane scaffold, unprecedented in polyketide natural products. The hypothetical biosynthetic pathways for 1 and 2 were postulated and were supported by CRISPR/Cas9 genome editing results. Penidaleodiolide A (1) showed a significant inhibitory effect on the action potentials of murine hippocampal basket neurons and decreased the frequency of spontaneous excitatory postsynaptic currents in a concentration-dependent manner (the inhibition ratios were 0.30 ± 0.02 for 1 µM, 0.37 ± 0.03 for 10 µM, and 0.50 ± 0.07 for 20 µM) while being devoid of cytotoxicity against the nerve cells.


Subject(s)
Penicillium , Polyketides , Polyketides/chemistry , Polyketides/pharmacology , Polyketides/isolation & purification , Penicillium/chemistry , Penicillium/metabolism , Animals , Mice , Molecular Structure , Synaptic Transmission/drug effects , Soil Microbiology , Neurons/drug effects , Hippocampus/metabolism
7.
J Agric Food Chem ; 72(39): 21318-21343, 2024 Oct 02.
Article in English | MEDLINE | ID: mdl-39302874

ABSTRACT

Bacterial trans-acyltransferase polyketide synthases (trans-AT PKSs) are among the most complex enzymes, which are responsible for generating a wide range of natural products, identified as trans-AT polyketides. These polyketides have received significant attention in drug development due to their structural diversity and potent bioactivities. With approximately 300 synthesized molecules discovered so far, trans-AT PKSs are found widespread in bacteria. Their biosynthesis pathways exhibit considerable genetic diversity, leading to the emergence of numerous enzymes with novel mechanisms, serving as a valuable resource for genetic engineering aimed at modifying small molecules' structures and creating new engineered enzymes. Despite the systematic discussions on trans-AT polyketides and their biosynthesis in earlier studies, the continuous advancements in tools, methods, compound identification, and biosynthetic pathways require a fresh update on accumulated knowledge. This review seeks to provide a comprehensive discussion for the 27 types of trans-AT polyketides discovered within the last seven years, detailing their sources, structures, biological activities, and biosynthetic pathways. By reviewing this new knowledge, a more profound understanding of the trans-AT polyketide family can be achieved.


Subject(s)
Bacteria , Biosynthetic Pathways , Polyketide Synthases , Polyketides , Polyketides/metabolism , Polyketides/chemistry , Polyketide Synthases/metabolism , Polyketide Synthases/genetics , Polyketide Synthases/chemistry , Bacteria/metabolism , Bacteria/genetics , Bacteria/enzymology , Bacterial Proteins/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/chemistry , Drug Discovery , Humans
8.
Gut Microbes ; 16(1): 2397874, 2024.
Article in English | MEDLINE | ID: mdl-39229962

ABSTRACT

Recently, the mounting integration of probiotics into human health strategies has gathered considerable attention. Although the benefits of probiotics have been widely recognized in patients with gastrointestinal disorders, immune system modulation, and chronic-degenerative diseases, there is a growing need to evaluate their potential risks. In this context, new concerns have arisen regarding the safety of probiotics as some strains may have adverse effects in humans. Among these strains, Escherichia coli Nissle 1917 (EcN) exhibited traits of concern due to a pathogenic locus in its genome that produces potentially genotoxic metabolites. As the use of probiotics for therapeutic purposes is increasing, the effects of potentially harmful probiotics must be carefully evaluated. To this end, in this narrative review article, we reported the findings of the most relevant in vitro and in vivo studies investigating the expanding applications of probiotics and their impact on human well-being addressing concerns arising from the presence of antibiotic resistance and pathogenic elements, with a focus on the polyketide synthase (pks) pathogenic island of EcN. In this context, the literature data here discussed encourages a thorough profiling of probiotics to identify potential harmful elements as done for EcN where potential genotoxic effects of colibactin, a secondary metabolite, were observed. Specifically, while some studies suggest EcN is safe for gastrointestinal health, conflicting findings highlight the need for further research to clarify its safety and optimize its use in therapy. Overall, the data here presented suggest that a comprehensive assessment of the evolving landscape of probiotics is essential to make evidence-based decisions and ensure their correct use in humans.


Subject(s)
Escherichia coli , Peptides , Polyketides , Probiotics , Escherichia coli/genetics , Escherichia coli/metabolism , Humans , Polyketides/metabolism , Peptides/metabolism , Peptides/genetics , Animals , Mutagens/metabolism , Mutagens/toxicity , DNA Damage , Polyketide Synthases/genetics , Polyketide Synthases/metabolism
9.
Curr Microbiol ; 81(11): 379, 2024 Sep 28.
Article in English | MEDLINE | ID: mdl-39340701

ABSTRACT

Streptomyces bikiniensis HD-087 is capable of synthesizing various antimicrobial substances to counter the detrimental effects of hazardous microorganisms. To elucidate whether it produces polyketide antibiotics and the synthesis mechanism of antibiotic substances, the metabolites and related genes of S. bikiniensis HD-087 were analyzed through LC-MS, anti-Magnaporthe oryzae activity detection, and bioinformatics approaches. The result indicated that the strain HD-087 could produce erythromycin, a polyketide antibiotic. The inhibitory zones of the fermentation supernatant of strain HD-087 and methanol solution of erythromycin extract against M. oryzae were 40.84 ± 0.68 mm and 33.18 ± 0.81 mm, respectively. The IC50 value of erythromycin extract for inhibiting spore germination of erythromycin extract was 220.43 µg/mL. There are two polyketide synthesis gene clusters in the genome of strain HD-087, namely t1pks-nrps and t3pks-lantipeptide-t1pks-nrps. The key gene pksL in the t3pks-lantipeptide-t1pks-nrps gene cluster was predicted. The results suggested that it encodes a stable, hydrophilic, and acidic protein, mainly composed of α-helix and random coil. The PksL protein contains dehydrogenase (DH), ketone reductase (KR), acyl carrier protein (ACP), and ketone synthase (KS) domains. Moreover, it can form interaction networks with 11 proteins containing domains, such as polyketide synthase and ACP synthase. The molecular docking between PksL and acetyl-CoA is stable and strong, suggesting that PksL protein could catalyze the synthesis of polyketides with CoA as a substrate. This study provides a theoretical basis for further exploring the polyketides synthesis mechanism and developing antifungal metabolites in S. bikiniensis HD-087.


Subject(s)
Computational Biology , Multigene Family , Polyketide Synthases , Streptomyces , Polyketide Synthases/genetics , Polyketide Synthases/metabolism , Streptomyces/genetics , Streptomyces/metabolism , Streptomyces/enzymology , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Erythromycin/pharmacology , Antifungal Agents/pharmacology , Antifungal Agents/metabolism , Polyketides/metabolism , Polyketides/pharmacology , Anti-Bacterial Agents/pharmacology , Molecular Docking Simulation , Ascomycota
10.
Curr Opin Chem Biol ; 82: 102510, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39128325

ABSTRACT

Mushroom-forming fungi exhibit a distinctive ecology, which is unsurprisingly also reflected in unique and divergent biosynthetic pathways. We review this phenomenon through the lens of the polyketide metabolism, where mushrooms often deviate from established principles and challenge conventional paradigms. This is evident not only by non-canonical enzyme architectures and functions but also by their propensity for multi-product synthases rather than single-product pathways. Nevertheless, mushrooms also feature many polyketides familiar from plants, bacteria, and fungi of their sister division Ascomycota, which, however, are the result of an independent evolution. In this regard, the captivating biosynthetic pathways of mushrooms might even help us understand the biological pressures that led to the simultaneous production of the same natural products (via convergent evolution, co-evolution, and/or metaevolution) and thus address the question of their raison d'être.


Subject(s)
Agaricales , Polyketide Synthases , Polyketide Synthases/metabolism , Polyketide Synthases/genetics , Agaricales/enzymology , Agaricales/metabolism , Polyketides/metabolism , Polyketides/chemistry , Biosynthetic Pathways , Biological Products/metabolism , Biological Products/chemistry
11.
Mar Drugs ; 22(8)2024 Jul 24.
Article in English | MEDLINE | ID: mdl-39195448

ABSTRACT

Co-cultivation is a powerful emerging tool for awakening biosynthetic gene clusters (BGCs) that remain transcriptionally silent under artificial culture conditions. It has recently been used increasingly extensively to study natural interactions and discover new bioactive metabolites. As a part of our project aiming at the discovery of structurally novel and biologically active natural products from mangrove endophytic fungi, an established co-culture of a strain of Phomopsis asparagi DHS-48 with another Phomopsis genus fungus DHS-11, both endophytes in mangrove Rhizophora mangle, proved to be very efficient to induce the production of new metabolites as well as to increase the yields of respective target metabolites. A detailed chemical investigation of the minor metabolites produced by the co-culture of these two titled fungal strains led to the isolation of six alkaloids (1-6), two sterols (7, 8), and six polyketides (9-14). In addition, all the compounds except 8 and 10, as well as three new metabolites phomopyrazine (1), phomosterol C (7), and phomopyrone E (9), were not present in discrete fungal cultures and only detected in the co-cultures. The structures were elucidated on the basis of spectroscopic analysis, and the absolute configurations were assumed by electronic circular dichroism (ECD) calculations. Subsequently, the cytotoxic, immunosuppressive, and acetylcholinesterase inhibitory properties of all the isolated metabolites were determined in vitro. Compound 8 exhibited moderate inhibitory activity against ConA-induced T and LPS-induced B murine splenic lymphocytes, with IC50 values of 35.75 ± 1.09 and 47.65 ± 1.21 µM, respectively.


Subject(s)
Coculture Techniques , Endophytes , Phomopsis , Rhizophoraceae , Animals , Mice , Alkaloids/pharmacology , Alkaloids/isolation & purification , Alkaloids/chemistry , Biological Products/pharmacology , Biological Products/chemistry , Biological Products/isolation & purification , Cholinesterase Inhibitors/pharmacology , Cholinesterase Inhibitors/isolation & purification , Endophytes/metabolism , Phomopsis/metabolism , Polyketides/metabolism , Polyketides/pharmacology , Polyketides/isolation & purification , Polyketides/chemistry , Rhizophoraceae/microbiology , Secondary Metabolism
12.
Mar Drugs ; 22(8)2024 Aug 08.
Article in English | MEDLINE | ID: mdl-39195476

ABSTRACT

Four new polyketides, namely furantides A-B (1-2), talamin E (3) and arugosinacid A (4), and two known polyketides were obtained from the mangrove-derived fungus Penicillium sp. HDN15-312 using the One Strain Many Compounds (OSMAC) strategy. Their chemical structures, including configurations, were elucidated by detailed analysis of extensive NMR spectra, HRESIMS and ECD. The DPPH radicals scavenging activity of 3, with an IC50 value of 6.79 µM, was better than vitamin C.


Subject(s)
Penicillium , Polyketides , Penicillium/chemistry , Polyketides/pharmacology , Polyketides/chemistry , Polyketides/isolation & purification , Free Radical Scavengers/pharmacology , Free Radical Scavengers/chemistry , Free Radical Scavengers/isolation & purification , Magnetic Resonance Spectroscopy , Molecular Structure , Picrates , Rhizophoraceae/microbiology , Biphenyl Compounds
13.
Biochemistry ; 63(18): 2240-2244, 2024 Sep 17.
Article in English | MEDLINE | ID: mdl-39186058

ABSTRACT

Engineered type I polyketide synthases (type I PKSs) can enable access to diverse polyketide pharmacophores and generate non-natural natural products. However, the promise of type I PKS engineering remains modestly realized at best. Here, we report that ketosynthase (KS) domains, the key carbon-carbon bond-forming catalysts, control which intermediates are allowed to progress along the PKS assembly lines and which intermediates are excluded. Using bimodular PKSs, we demonstrate that KSs can be exquisitely selective for the upstream polyketide substrate while retaining promiscuity for the extender unit that they incorporate. It is then the downstream KS that acts as a gatekeeper to ensure the fidelity of the extender unit incorporation by the upstream KS. We also demonstrate that these findings are not universally applicable; substrate-tolerant KSs do allow engineered polyketide intermediates to be extended. Our results demonstrate the utility for evaluating the KS-induced bottlenecks to gauge the feasibility of engineering PKS assembly lines.


Subject(s)
Polyketide Synthases , Protein Engineering , Polyketide Synthases/metabolism , Polyketide Synthases/chemistry , Polyketide Synthases/genetics , Protein Engineering/methods , Polyketides/metabolism , Polyketides/chemistry , Substrate Specificity , Protein Domains
14.
Science ; 385(6709): 671-678, 2024 08 09.
Article in English | MEDLINE | ID: mdl-39116217

ABSTRACT

Prymnesium parvum are harmful haptophyte algae that cause massive environmental fish kills. Their polyketide polyether toxins, the prymnesins, are among the largest nonpolymeric compounds in nature and have biosynthetic origins that have remained enigmatic for more than 40 years. In this work, we report the "PKZILLAs," massive P. parvum polyketide synthase (PKS) genes that have evaded previous detection. PKZILLA-1 and -2 encode giant protein products of 4.7 and 3.2 megadaltons that have 140 and 99 enzyme domains. Their predicted polyene product matches the proposed pre-prymnesin precursor of the 90-carbon-backbone A-type prymnesins. We further characterize the variant PKZILLA-B1, which is responsible for the shorter B-type analog prymnesin-B1, from P. parvum RCC3426 and thus establish a general model of haptophyte polyether biosynthetic logic. This work expands expectations of genetic and enzymatic size limits in biology.


Subject(s)
Haptophyta , Polyether Toxins , Polyketide Synthases , Haptophyta/enzymology , Haptophyta/genetics , Polyenes/metabolism , Polyenes/chemistry , Polyether Toxins/biosynthesis , Polyketide Synthases/genetics , Polyketide Synthases/metabolism , Polyketides/metabolism , Protein Domains
15.
Genes (Basel) ; 15(8)2024 Aug 05.
Article in English | MEDLINE | ID: mdl-39202389

ABSTRACT

Lichens have developed numerous adaptations to optimize their survival in various environmental conditions, largely by producing secondary compounds by the fungal partner. They often have antibiotic properties and are involved in protection against intensive UV radiation, pathogens, and herbivores. To contribute to the knowledge of the arsenal of secondary compounds in a crustose lichen species, we sequenced and assembled the genome of Toniniopsis dissimilis, an indicator of old-growth forests, using Oxford Nanopore Technologies (ONT, Oxford, UK) long reads. Our analyses focused on biosynthetic gene clusters (BGCs) and specifically on Type I Polyketide (T1PKS) genes involved in the biosynthesis of polyketides. We used the comparative genomic approach to compare the genome of T. dissimilis with six other members of the family Ramalinaceae and twenty additional lichen genomes from the database. With only six T1PKS genes, a comparatively low number of biosynthetic genes are present in the T. dissimilis genome; from those, two-thirds are putatively involved in melanin biosynthesis. The comparative analyses showed at least three potential pathways of melanin biosynthesis in T. dissimilis, namely via the formation of 1,3,6,8-tetrahydroxynaphthalene, naphthopyrone, or YWA1 putative precursors, which highlights its importance in T. dissimilis. In addition, we report the occurrence of genes encoding ribosomally synthesized and posttranslationally modified peptides (RiPPs) in lichens, with their highest number in T. dissimilis compared to other Ramalinaceae genomes. So far, no function has been assigned to RiPP-like proteins in lichens, which leaves potential for future research on this topic.


Subject(s)
Genome, Fungal , Lichens , Melanins , Melanins/biosynthesis , Melanins/genetics , Lichens/genetics , Lichens/metabolism , Multigene Family , Phylogeny , Biosynthetic Pathways/genetics , Ascomycota/genetics , Ascomycota/metabolism , Polyketides/metabolism , Fungal Proteins/genetics , Fungal Proteins/metabolism
16.
Fitoterapia ; 178: 106154, 2024 Oct.
Article in English | MEDLINE | ID: mdl-39089594

ABSTRACT

Besides plants and animals, the fungal kingdom consists of several species characterized by various forms and applications. Fungi are amazing producers of bioactive natural products with applications in medicine and agriculture. Though this kingdom has been extensively investigated worldwide, it remains relatively underexplored in Africa. To address the knowledge gaps, encourage research interest, and suggest opportunities for the discovery of more bioactive substances from African fungi, we considered it appropriate to extensively review the research work carried out on African fungi since 1988. This review summarizes the diversity and distribution of fungi throughout Africa, the secondary metabolites yet reported from studied fungi, their biological activities and, the countries where they were collected. The studied fungi originated from eleven African countries and were mainly endophytic fungi and higher fungi (macrofungi). Their investigation led to the isolation of five hundred and three (503) compounds with polyketides representing the main class of secondary metabolites. The compounds exhibited varied biological activities with antibacterial and antiproliferative properties being the most prominent.


Subject(s)
Biological Products , Fungi , Africa , Biological Products/pharmacology , Biological Products/chemistry , Biological Products/isolation & purification , Molecular Structure , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/isolation & purification , Endophytes/chemistry , Secondary Metabolism , Polyketides/pharmacology , Polyketides/isolation & purification , Polyketides/chemistry
17.
Org Lett ; 26(36): 7489-7494, 2024 Sep 13.
Article in English | MEDLINE | ID: mdl-39194005

ABSTRACT

Six new angucycline structures, including spirocyclione A (1), which contains an unusual oxaspiro[5.5]undecane architecture, and its ring-A-cleaved product spirocyclione B (2), were discovered by heterologous expression of a type II polyketide biosynthetic gene cluster captured from a marine actinomycete strain Streptomyces sp. HDN155000. Three flavoprotein monooxygenases are confirmed to be responsible for the oxidative carbon skeleton rearrangements in the biosynthesis of compounds 1 and 2. The obtained compounds showed promising cytotoxicity against different types of cancer cells.


Subject(s)
Mixed Function Oxygenases , Streptomyces , Streptomyces/enzymology , Streptomyces/chemistry , Streptomyces/metabolism , Mixed Function Oxygenases/metabolism , Molecular Structure , Multigene Family , Flavoproteins/metabolism , Flavoproteins/chemistry , Humans , Drug Screening Assays, Antitumor , Catalysis , Spiro Compounds/chemistry , Spiro Compounds/metabolism , Polyketides/chemistry , Polyketides/metabolism , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Antineoplastic Agents/metabolism , Anthraquinones/chemistry , Anthraquinones/metabolism , Angucyclines and Angucyclinones
18.
Microbiol Spectr ; 12(10): e0086424, 2024 Oct 03.
Article in English | MEDLINE | ID: mdl-39162518

ABSTRACT

Mammals host a remarkable diversity and abundance of gut microbes. Biosynthetic gene clusters (BGCs) in microbial genomes encode biologically active chemical products and play an important role in microbe-host interactions. Traditionally, the exploration of gut microbial metabolic functions has relied on the pure culture method. However, given the limited amounts of microbes being cultivated, insights into the metabolism of gut microbes in mammals continued to be very limited. In this study, we adopted a computational pipeline for mining the metagenomic data (named taxonomy-guided identification of biosynthetic gene clusters, TaxiBGC) to identify experimentally verified BGCs in 373 metagenomes across 53 mammalian species in an unbiased manner. We demonstrated that polyketides (PKs) and nonribosomal peptides (NRPs) are representative of mammals, and the products derived from them were associated with cell-cell communication and resistance to inflammation. Large carnivores had the highest number of BGCs, followed by large herbivores and small mammals. We also observed that the large mammals had more common BGCs that aid in the biosynthesis of a variety of natural products. However, small mammals not only had fewer BGCs but were also unique to each species. Our results provide novel insights into the mining of metagenomic data sets to identify active BGCs and their products across mammals.IMPORTANCEThe gut microbes host numerous biosynthetic gene clusters (BGCs) that biosynthesize natural products and impact the host's physiology. Historically, our understanding of BGCs in mammalian gut microbes was largely based on studies on cultured isolates; however, only a small fraction of mammal-associated microbes have been investigated. The biochemical diversity of the mammalian gut microbiota is poorly understood. Metagenomic sequencing contains data from a vast number of organisms and provides information on the total gene content of communities. Unfortunately, the existing BGC prediction tools are designed for individual microbial genomes. Recently, a BGC prediction tool called the taxonomy-guided identification of biosynthetic gene clusters (TaxiBGC) that directly mine the metagenome was developed. To gain new insights into the microbial metabolism, we used TaxiBGC to predict BGCs from 373 metagenomes across 53 mammalian species representing seven orders. Our findings elucidate the functional activities of complex microbial communities in the gut.


Subject(s)
Gastrointestinal Microbiome , Mammals , Metagenome , Metagenomics , Multigene Family , Animals , Gastrointestinal Microbiome/genetics , Mammals/microbiology , Bacteria/genetics , Bacteria/classification , Bacteria/metabolism , Polyketides/metabolism , Data Mining , Biological Products/metabolism , Female , Biosynthetic Pathways/genetics
19.
Curr Opin Chem Biol ; 81: 102507, 2024 Aug.
Article in English | MEDLINE | ID: mdl-39098210

ABSTRACT

Polyketides represent an important class of natural products, renowned for their intricate structures and diverse biological activities. In contrast to common fatty acids, polyketides possess relatively more rigid carbon skeletons, more complex ring systems, and chiral centers. These structural features are primarily achieved through distinctive enzymatic cyclizations and oxidations as tailoring steps. In this opinion, we discuss the recent progress in deciphering the mechanisms of cyclization and oxidation within polyketide biosynthesis. By shedding light on these enzymatic processes, this article seeks to motivate the community to unravel the remaining mysteries surrounding cyclase and oxidase functionalities and to explore novel polyketide natural products through genome mining.


Subject(s)
Oxidation-Reduction , Polyketides , Polyketides/metabolism , Polyketides/chemistry , Cyclization , Biological Products/metabolism , Biological Products/chemistry , Polyketide Synthases/metabolism
20.
Gut Microbes ; 16(1): 2387877, 2024.
Article in English | MEDLINE | ID: mdl-39133871

ABSTRACT

Colibactin is a recently characterized pro-carcinogenic genotoxin produced by pks+ Escherichia coli. We hypothesized that cystic fibrosis (CF)-associated dysfunctional mucus structure increases the vulnerability of host mucosa to colibactin-induced DNA damage. In this pilot study, we tested healthy-appearing mucosal biopsy samples obtained during screening and surveillance colonoscopies of adult CF and non-CF patients for the presence of pks+ E. coli, and we investigated the possibility of detecting a novel colibactin-specific DNA adduct that has not been yet been demonstrated in humans. While CF patients had a lower incidence of pks+ E. coli carriage (~8% vs 29%, p = 0.0015), colibactin-induced DNA adduct formation was detected, but only in CF patients and only in those who were not taking CFTR modulator medications. Moreover, the only patient found to have colon cancer during this study had CF, harbored pks+ E. coli, and had colibactin-induced DNA adducts in the mucosal samples. Larger studies with longitudinal follow-up should be done to extend these initial results and further support the development of colibactin-derived DNA adducts to stratify patients and their risk.


Subject(s)
Colon , Cystic Fibrosis , DNA Adducts , Escherichia coli , Intestinal Mucosa , Mucus , Peptides , Polyketides , Cystic Fibrosis/microbiology , Cystic Fibrosis/metabolism , Humans , Polyketides/metabolism , DNA Adducts/metabolism , Adult , Escherichia coli/genetics , Escherichia coli/metabolism , Intestinal Mucosa/metabolism , Intestinal Mucosa/microbiology , Intestinal Mucosa/pathology , Peptides/metabolism , Male , Colon/microbiology , Colon/pathology , Colon/metabolism , Female , Pilot Projects , Mucus/metabolism , Mucus/microbiology , Middle Aged , Young Adult , Colonic Neoplasms/metabolism , Colonic Neoplasms/pathology
SELECTION OF CITATIONS
SEARCH DETAIL